Background: Ethanol (EtOH) exposure during pregnancy may result in fetal alcohol spectrum disorders (FASD). One of the most deleterious consequences of EtOH exposure is neuronal loss in the developing brain. Previously, we showed that EtOH exposure induced neuroapoptosis in the brain of postnatal day 4 (PD4) mice but not PD12 mice. This differential susceptibility may result from an insufficient cellular stress response system such as unfolded protein response (also known as endoplasmic reticulum [ER] stress) in PD4 mice. In this study, we compared the effect of EtOH on ER stress in PD4 and PD12 mice and determined whether the inhibition of ER stress could protect the developing brain against EtOH damage.
F
ETAL ALCOHOL EXPOSURE may cause damage to the developing fetus, which leads to fetal alcohol spectrum disorders (FASD). The developing central nervous system (CNS) is particularly vulnerable to ethanol (EtOH) exposure. Neuronal loss in the developing CNS is one of the most devastating consequences of EtOH exposure which may account for many symptoms associated with FASD patients. The mechanisms underlying EtOH-induced neuronal loss, however, are complex and remain unclear. Animal models for FASD have demonstrated a temporal window of neuron susceptibility to EtOH toxicity (Maier et al., 1999; Siler-Marsiglio et al., 2006) .
The endoplasmic reticulum (ER) regulates the folding, maturation, and export of most secreted and transmembrane proteins. Under some cellular stress conditions, unfolded or misfolded proteins accumulate in the ER and trigger intracellular signal transduction pathways cumulatively known as ER stress response or unfolded protein response (UPR) (Ron, 2002; Xu et al., 2005) . The ER stress response or UPR is mediated by 3 transmembrane ER sensor proteins: pancreatic endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1a (IRE1a), and activating transcription factor 6 (ATF6). These sensors are occupied by 78-kDa glucose-regulated protein (GRP78) which prevents their activation. Accumulation of unfolded/misfolded proteins in the ER results in the disassociation of ER sensors with GRP78 and the subsequent activation of the sensors. PERK is a Ser/Thr protein kinase; when activated, it phosphorylates Eukaryotic Initiation Factor 2 alpha subunit (eIF2a), resulting in the inhibition of translation. IRE1a is a bifunctional kinase and endoribonuclease. Oligomerization of IRE1a excises 1 intron of its target mRNA x-box binding protein 1 (XBP1). Spliced XBP1 mRNA codes for the active form of the transcription factor XBP1s. XBP1s regulate genes involved in protein folding and ER-associated protein degradation. Upon ER stress, ATF6 translocates from ER to the Golgi apparatus where it is cleaved and acts as a transcription factor to regulate UPR genes. The activation of these transducers results in protective adaptive responses to improve protein folding and lowering protein synthesis (Ron, 2002) . However, sustained ER stress ultimately leads to irreversible damage and cell death (Rasheva and Domingos, 2009; Xu et al., 2005) . We previously demonstrated that EtOH exposure increased a number of ER stress markers in multiple brain regions of early postnatal mice (Ke et al., 2011) . Interestingly, in an effort to compare the expression profile of genes involved in apoptosis and ER stress markers in developing brains, we discovered that pro-apoptotic effectors are expressed at higher levels, whereas genes involved in UPR are expressed at lower levels in the brain of postnatal day 4 (PD4) mice (alcohol-sensitive period) compared to PD12 (alcohol-resistant period) (Alimov et al., 2013) . Therefore, we hypothesized that ER stress plays an important role in neuroapoptosis and the vulnerability of developing brains may result from inadequate UPR systems to couple with ER stress.
Sodium 4-phenylbutyric acid (4-PBA) is often considered an "ER stress inhibitor" primarily due to its properties as a chemical chaperone to improve protein folding and reduce ER stress in multiple disorders (Mimori et al., 2012; Mizukami et al., 2010; Qi et al., 2004) . 4-PBA has been approved for clinical use to treat protein-folding diseases (Burrows et al., 2000; Perlmutter, 2002; Rubenstein and Zeitlin, 2000) . Despite the fact that EtOH exposure can cause ER stress, it is unclear whether 4-PBA provides protection against EtOHinduced neurotoxicity. In this study, we aimed to determine whether 4-PBA protects neurons against EtOH-induced damage in the cerebral cortex and the underlying mechanisms. Our results showed the treatment of 4-PBA alleviated EtOH-induced neuroapoptosis, glial activation, and ER stress responses, suggesting 4-PBA can be a potential therapeutic agent for FASD.
MATERIALS AND METHODS

Materials
4-PBA was purchased from Sigma Chemical Co. (St. Louis, MO). Anti-GRP78, anti-eIF2a, and anti-ATF6 antibodies were obtained from Santa Cruz Biotech (Santa Cruz, CA). Anti-cleaved caspase-3, anti-phospho-eIF2a (Ser51), and anti-IRE1a antibodies were obtained from Cell Signaling Technology, Inc. (Beverly, MA). Anti-phospho-IRE1a (Ser724), anti-mesencephalic astrocytederived neurotrophic factor (MANF), and anti-caspase-12 antibodies were obtained from Abcam (Cambridge, MA). Anti-ionized calcium binding adaptor molecule 1 (Iba-1) antibody was purchased from Wako Chemicals USA, Inc. (Richmond, VA). Anti-glial fibrillary acidic protein (GFAP) antibody was obtained from Sigma Chemical Co. Ketamine and xylazine were obtained from Henry Schein Animal Health (Dublin, OH).
Animals and Treatment
C57BL/6 mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained at the Animal Facility of the University of Kentucky Medical Center. All procedures were performed in accordance with the guidelines set by the National Institutes of Health and the Animal Care and Use Committee of the University of Kentucky. A well-established mouse model of postnatal EtOH exposure was employed (Alimov et al., 2013; Ke et al., 2011; Liu et al., 2009; Olney et al., 2002; Young et al., 2008) . PD4 or PD12 mouse pups were weighed and randomly assigned to 4 groups: control (saline), EtOH, EtOH plus 4-PBA, and 4-PBA alone. Each pup in control or EtOH group was injected subcutaneously with saline or EtOH (2.5 g/kg, 20% solution in saline) twice at time 0 and 2 hours. Eight hours after the first EtOH injection, the brains were removed and processed for immunoblotting or immunohistochemical analysis. For chemical inhibition of ER stress, pups received 4-PBA diluted in phosphate-buffered saline (PBS) at a dose of 100 mg/kg 1 day and 0.5 hours prior to EtOH exposure by injection. The concentration was selected based on previous studies of 4-PBA injection in neonatal or adult animals (Carlisle et al., 2014; Jeanne et al., 2015; Shimizu et al., 2014) . Pups of both genders were used in this study, and we did not analyze male and female animals separately.
Preparation of Protein Extracts and Immunoblotting
The procedure for the preparation of protein extracts from brain tissues has been previously described (Alimov et al., 2013; Ke et al., 2011) . Briefly, mice were anesthetized by an intraperitoneal injection of ketamine (100 mg/kg)/xylazine (10 mg/kg), and the brain was immediately dissected. The tissues were frozen in liquid nitrogen and stored at À80°C. The tissues were homogenized using an icecold lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM ethylene glycol-bis(b-aminoethyl ether)-N,N,N 0 ,N 0 -tetraacetic acid (EGTA), 1 mM phenylmethane sulfonyl fluoride (PMSF), 0.5% NP-40, 0.25% SDS, 5 lg/ml leupeptin, and 5 lg/ml aprotinin. Homogenates were centrifuged at 20,0009 g for 30 minutes at 4°C, and the supernatant fraction was collected.
The immunoblotting procedure has been previously described (Alimov et al., 2013; Ke et al., 2011) . In brief, aliquots of the protein samples (30 lg) were separated on an SDS-polyacrylamide gel by electrophoresis. The separated proteins were transferred to nitrocellulose membranes. The membranes were blocked with either 5% bovine serum albumin (BSA) or 5% nonfat milk in 0.01 M PBS (pH 7.4) and 0.05% Tween-20 (TBST) at room temperature for 1 hour. Subsequently, the membranes were probed with primary antibodies directed against target proteins overnight at 4°C. The final dilutions for primary antibodies were as follows: anti-cleaved caspase-3 antibody, 1:1,000; anti-p-eIF2a (Ser51) antibody 1:1,000; anti-eIF2a antibody 1:1,000; anti-ATF6 antibody 1:1,000; anti-GRP78 antibody 1:1,000; anti-p-IRE1a (Ser724) antibody 1:1,000; anti-IRE1a antibody 1:1,000; anti-caspase-12 antibody 1:1,000; anti-MANF antibody 1:1,000; anti-Iba-1 antibody 1:1,000; anti-GFAP antibody 1:1,000; and anti-actin antibody 1:5,000. After 3 quick washes in TBST, the membranes were incubated with a secondary antibody conjugated to horseradish peroxidase (Amersham, Arlington Heights, IL). The immune complexes were detected by the enhanced chemiluminescence method (Amersham). The density of immunoblotting was quantified with the software of Quantity One (Bio-Rad Laboratories, Hercules, CA).
Immunohistochemistry
After treatments, the mice were anesthetized with ketamine/xylazine and then perfused with saline followed by 4% paraformaldehyde in 0.1 M potassium phosphate buffer (pH 7.2). The brains were removed and postfixed in 4% paraformaldehyde for an additional 24 hours and then transferred to 30% sucrose. The brain was sectioned at 40 lm with a sliding microtome (Leica Microsystems, Wetzlar, Germany).
The procedure for immunohistochemistry (IHC) staining has been previously described (Alimov et al., 2013; Ke et al., 2011) . In brief, the mounted sections were incubated in 0.3% H 2 O 2 in methanol for 30 minutes at room temperature and then treated with 0.1% Triton X-100 for 10 minutes in PBS. The sections were washed with PBS 3 times and then blocked with 1% BSA and 0.01% Triton X-100 for 1 hour at room temperature. The sections were incubated with an anti-cleaved caspase-3 antibody (1:1,000), anti-p-eIF2a antibody (1:500), anti-caspase-12 antibody (1:1,000), anti-MANF antibody (1:1,000), anti-Iba-1 antibody (1:1,000), or anti-GFAP antibody (1:1,000) overnight at 4°C. Negative controls were performed by omitting the primary antibody. After rinsing in PBS, sections were incubated with a biotinylated goat anti-rabbit IgG (Vector Laboratories Inc., Burlingame, CA; 1:200) for 1 hour at room temperature. The sections were washed 3 times with PBS, then incubated in avidin-biotin-peroxidase complex (Vector Laboratories Inc.; 1:100 in PBS) for 1 hour and developed in 0.05% 3,3 0 -diaminobenzidine (Sigma-Aldrich) containing 0.003% H 2 O 2 in PBS. The images were recorded using an Olympus microscope (BX61) equipped with a DP70 digital camera (Olympus Corporation, Tokyo, Japan).
Statistical Analysis
All analyses were performed using the SPSS software (SPSS, Chicago, IL). The data were expressed as mean AE SEM. Differences among experimental groups were analyzed by 1-way analysis of variance. Differences in which the p-value was less than 0.05 were considered statistically significant. In cases where significant differences were detected, specific post hoc comparisons between treatment groups were examined with the Tukey test.
RESULTS
4-PBA Decreases EtOH-Induced Caspase-3 Activation in the Brain of PD4 Mice
Consistent with previous findings, we observed that EtOH increased the expression of cleaved caspase-3 (c-caspase-3), an apoptosis marker in the cerebral cortex of PD4 mice, F(3, 8) = 15.7, p = 0.001, but not PD12 mice by immunoblotting (Fig. 1A,B) . This result was further confirmed by the increase of IHC staining of c-caspase-3 in the cerebral cortex of PD4 mice, F(3, 12) = 11.8, p = 0.001 (Fig. 1C) but not in PD12 mice (data not shown). To investigate whether 4-PBA can protect brains from EtOH-induced damage, we administered 4-PBA (100 mg/kg) 1 day and 0.5 hours prior to EtOH exposure by subcutaneous injection on PD4 or PD12. The concentration was selected based on previous studies of 4-PBA injections in neonatal or adult animals (Carlisle et al., 2014; Jeanne et al., 2015; Shimizu et al., 2014) . 4-PBA significantly reduced EtOH-induced expression of c-caspase-3 in the cerebral cortex as shown by immunoblot (p = 0.001) and IHC (p = 0.004) (Fig. 1A-C) . The treatment of 4-PBA alone, however, does not have a significant effect on the expression of c-caspase-3.
4-PBA Alleviates EtOH-Induced ER Stress in the Brain of PD4 Mice ER stress has been proposed to play a vital role in EtOHinduced brain damage (Ke et al., 2011) . We have previously demonstrated that the brain develops more effective defensive systems, such as UPR, as it matures shown by the higher expression levels of UPR genes in the EtOH-resistant PD12 mice than the EtOH-sensitive PD4 mice (Alimov et al., 2013) . To determine whether ER stress may account for the differential effects of EtOH exposure to PD4 and PD12 brains, we examined the expression of a group of ER stress markers in the cerebral cortex by immunoblot. In PD4 mice, EtOH significantly increased the expression of ATF6, F(3, (Fig. 2A) . While 4-PBA alone had little effect on the basal level of the selected ER stress markers, it abolished the EtOH-induced increase of these proteins. Compared with the EtOH-treated group, 4-PBA significantly decreased EtOH-induced expression of ATF6 (p = 0.003), GRP78 (p = 0.037), MANF (p = 0.007), p-IRE1a (p = 0.010), p-eIF2a (p = 0.023), and caspase-12 (p = 0.027). In contrast, neither EtOH exposure nor treatment of 4-PBA has an effect on the expression of these ER stress markers in PD12 mice (Fig. 2B) .
Additional IHC staining was performed on MANF, peIF2a, and caspase-12 in PD4 brains, and the results were consistent with that of immunoblotting. EtOH significantly increased the expression of caspase-12, F(3, 12) = 9.6, p = 0.002, p-eIF2a, F(3, 12) = 11.7, p = 0.001, and MANF, F(3, 12) = 7.7, p = 0.004, in PD4 cerebral cortex. While 4-PBA alone had little effect on these proteins, it significantly decreased EtOH-induced expression of caspase-12 (p = 0.038), p-eIF2a (p = 0.04), and MANF (p = 0.042).
4-PBA Inhibits EtOH-Induced Glial Activation in the Brain of PD4 Mice
Astrocytes and microglia are the 2 main types of glial cells in the CNS that normally provide support and protect neurons. They can be activated under pathological conditions to either release proinflammatory factors or phagocytose apoptotic neurons and release anti-inflammatory mediators (Saito et al., 2016) . To address whether astrocytes and microglia are activated by EtOH exposure, we examined the expression of Iba-1 for microglia and GFAP for astrocytes in the cerebral cortex of PD4 and PD12 brains. As shown by Fig. 3A,B , EtOH increased the expression of Iba-1, F(3, 8) = 6.5, p = 0.016, and GFAP, F(3, 8) = 13.0, p = 0.002 in PD4 mice but not in PD12 mice. Interestingly, 4-PBA restored the expression of Iba-1 (p = 0.048) and GFAP (p = 0.029) in PD4 brains, compared with the EtOH-treated group (Fig. 3A,C) . The immunoblot results were consistent with that of IHC staining (Fig. 3C) . EtOH significantly increased the expression Iba-1, F(3, 12) = 7.9, p = 0.003, and GFAP, F(3, 12) = 6.4, p = 0.008, in PD4 cerebral cortex, while 4-PBA blocked EtOH-induced expression of Iba-1 (p = 0.016) and GFAP (p = 0.017). 4-PBA alone had little effect on Iba-1 or GFAP.
DISCUSSION
Our previous studies suggest that ER stress may be involved in EtOH-induced neuroapoptosis and vulnerability of immure brain to EtOH exposure could result from a deficiency in the stress response system such as UPR (Alimov et al., 2013) . To test this hypothesis, we used a well-established mouse model for FASD to investigate EtOH-induced apoptosis, ER stress, and glia activation in the brain. Consistent with previous findings, we demonstrated c-caspase-3 is expressed at a higher level on PD4 than PD12, whereas UPR mediators including ATF6 and GRP78 are expressed at a Fig. 1 . Effect of ethanol (EtOH) and 4-PBA on the expression of cleaved caspase-3 (c-caspase-3) during development. C57BL/6 mice of PD4 or PD12 were exposed to EtOH for 8 hours with or without pretreatment of 4-PBA (100 mg/kg), then sacrificed and cerebral cortices were processed. (A) The expression of c-caspase-3 on PD4 was evaluated by immunoblotting as described in the Materials and Methods. Relative levels of c-caspase-3 were determined by densitometry and normalized to actin. (B) The expression of c-caspase-3 on PD12 was evaluated by immunoblotting and quantified. (C) C57BL/6 mice of PD4 were exposed to EtOH for 8 hours with or without pretreatment of 4-PBA (100 mg/kg), and then, sacrificed and cerebral cortices were processed for IHC. The number of c-caspase-3-positive cells in the cerebral cortex was determined in 20 randomly selected sections using the software Image Lab 5.2 (Bio-Rad Laboratories). Four or five animals were analyzed for each group. Bar = 200 lm in the upper panel and 50 lm in the lower panel. *Denotes significant difference (p < 0.05). Fig. 2 . Effect of ethanol (EtOH) and 4-PBA on the expression of ER stress markers during development. C57BL/6 mice of PD4 or PD12 were exposed to EtOH for 8 hours with or without pretreatment of 4-PBA (100 mg/kg), and then, sacrificed and cerebral cortices were processed. (A) The expression of ER stress markers, ATF6, GRP78, p-IRE1a, p-eIF2a, MANF, and caspase-12 was evaluated by immunoblotting as described in the Materials and Methods. Relative levels of these ER stress markers were determined by densitometry and normalized to actin. (B) The expression of the selected ER stress markers on PD12 was evaluated by immunoblotting and quantified. (C) C57BL/6 mice of PD4 were exposed to EtOH for 8 hours with or without pretreatment of 4-PBA (100 mg/kg), and then, sacrificed and cerebral cortices were processed for IHC. The number of MANF-, caspase-12-, or p-eIF2a-positive cells in the cerebral cortex was determined in 20 randomly selected sections using software of Image Lab 5.2. Four or five animals were analyzed for each group. Bar = 200 lm in the upper panel and 50 lm in the lower panel. *Denotes significant difference (p < 0.05). Fig. 3 . Effect of ethanol (EtOH) and 4-PBA on glial activation during development. C57BL/6 mice of PD4 or PD12 were exposed to EtOH for 8 hours with or without pretreatment of 4-PBA (100 mg/kg), and then, sacrificed and cerebral cortices were processed. (A) The expression of Iba-1 and glial fibrillary acidic protein (GFAP) was evaluated by immunoblotting as described in the Materials and Methods. Relative levels of the Iba-1 and GFAP were determined by densitometry and normalized to actin. (B) The expression of Iba-1 and GFAP on PD12 was evaluated by immunoblotting and quantified and normalized to actin. (C) C57BL/6 mice of PD4 were exposed to EtOH for 8 hours with or without pretreatment of 4-PBA (100 mg/kg), and then, sacrificed and cerebral cortices were processed for IHC. The number of Iba-1-and GFAP-positive cells in the cerebral cortex was determined in 20 randomly selected sections using software of Image Lab 5.2. Four or five animals were analyzed for each group. Bar = 200 lm in the upper panel and 50 lm in the lower panel. *Denotes significant difference (p < 0.05).
lower level on PD4 than PD12. The EtOH exposure regimen, 2 doses of 2.5 g/kg per dose with 2 hours apart, induced the expression of c-caspase-3 on PD4 but not PD12. It also increased a number of ER stress markers, including ATF6, GRP78, MANF, p-eIF2a, p-IRE1a, and caspase-12 as well as glial cell markers such as Iba-1 and GFAP on PD4 but not PD12. Strikingly, treatment of 4-PBA, a known ER stress inhibitor, not only suppresses the expression of the aforementioned ER stress markers, but also blocked the expression of c-caspase-3, suggesting ER stress contributes to EtOH neurotoxicity.
ER stress is an evolutionarily conserved cellular stress response that is initiated when sensor proteins at the ER membrane sense accumulation of unfolded/misfolded proteins (Hetz and Saxena, 2017; Ron and Walter, 2007; Walter and Ron, 2011) . Depending on the nature of the ER stress, downstream transcription or translation programs are triggered to either alleviate stress or result in cell death. In this study, we showed that IRE1a, one of the most evolutionarily conserved sensor proteins, is induced by EtOH exposure on PD4. IRE1a is a transmembrane ER-resident protein that has dual protein kinase and RNase activities (Iwawaki et al., 2001) . Once activated, IRE1a can autophosphorylate and regulate the splicing of XBP1 mRNA (Walter and Ron, 2011) . Spliced XBP1 encodes a transcription factor XBP1s that modulate many genes involved in protein folding and secretion and ER-associated degradation to maintain ER homeostasis (Acosta-Alvear et al., 2007; Hetz et al., 2011; Lee et al., 2003) . However, recent studies have indicated XBP1s can also target sequence-specific mRNAs for degradation through a process known as regulated IRE1a-dependent decay leading to cell death (Hetz et al., 2015; Maurel et al., 2014) . ATF6 is another ER stress sensor that is induced by EtOH in this study. Upon ER stress, ATF6 translocates to the Golgi apparatus and is cleaved by proteases. The N-terminal fragment of ATF6 acts as a transcription factor that moves into the nucleus and regulates the expression of XBP1 (Walter and Ron, 2011) and other UPR mediators such as GRP78 (Jørgensen et al., 2000) , leading to an increase in ER protein-folding capacity and ER homeostasis.
ER stress can lead to cell death, though the molecular mechanisms remain poorly understood (Hetz and Saxena, 2017) . Caspase-12 is an ER-residing caspase and can be activated by ER stress (Szegezdi et al., 2003; Yoneda et al., 2001) . Activation of caspase-12 has been reported in animal models and cell culture models for a number of neurodegenerative diseases and is believed to act on some downstream effectors including caspase-3 leading to cell death (Chun et al., 2001; Nakagawa et al., 2000; Oubrahim et al., 2002; Siman et al., 2001 ). Caspase-12-deficient mice are resistant to ER-directed pro-apoptotic signals, but their cells still undergo other apoptotic pathways, suggesting a central role of caspase-12 in ER stress-induced apoptosis (Nakagawa et al., 2000) . In this study, caspase-12 exhibited an expression pattern similar to c-caspase-3 upon EtOH exposure and treatment of ER stress inhibitor, suggesting caspase-12 is involved in EtOH-induced neuroapoptosis. However, future experiments using caspase-12-deficient mice or caspase-12 inhibitors are necessary to confirm the role of caspase-12 in EtOH neurotoxicity.
One of the molecular targets of ER stress transducers is MANF, which expression was also increased in EtOHexposed PD4 brains in this study. Two ER stress response elements (ERSE I and II) are located in the promoter region of MANF, which can be recognized by UPR mediators: cleaved ATF6 and spliced XBP1 (Mizobuchi et al., 2007; Oh-Hashi et al., 2013; Wang et al., 2018a) . MANF is up-regulated upon ER stress, and it can alleviate ER stress-induced neuronal cell death (Apostolou et al., 2008; Yu et al., 2010) . As a neurotrophic factor, MANF is required for the development and survival of neurons in normal or pathological conditions (Chen et al., 2012; Palgi et al., 2009; Petrova et al., 2003; Voutilainen et al., 2009) . It protects cortical neurons from ER stress-induced neurodegeneration caused by tunicamycin or thapsigargin treatment and cerebral ischemia (Airavaara et al., 2009 (Airavaara et al., , 2010 Apostolou et al., 2008; Huang et al., 2016) . It also attenuates neuronal damage in 6-hydroxydopamine-induced rat model of Parkinson's disease (Voutilainen et al., 2009 (Voutilainen et al., , 2011 . Recently, MANF was also reported to be required for retinal development in Drosophila (Walkowicz et al., 2017) and protected the degeneration of rod and cone photoreceptors in transgenic rats (Lu et al., 2018) . In this study, up-regulation of MANF may be a protective action in response to EtOH-induced ER stress.
Microglia and astrocytes are the 2 main types of glial cells that play important roles in many homeostatic processes in the CNS. Under pathological conditions, they can be activated to either release proinflammatory cytokines or phagocytose apoptotic neurons and release anti-inflammatory mediators; the imbalance between these functions can result in neuroinflammation and neurodegeneration (J€ akel and Dimou, 2017; Temburni and Jacob, 2001) . There are many studies showing that EtOH can activate microglia or astrocytes in experimental models for FASD and produce proinflammatory cytokines and reactive oxygen species that may contribute to the long-lasting cellular, physiological, and neurobehavioral deficits (Chastain and Sarkar, 2014; Kane and Drew, 2016; Li et al., 2015; Saito et al., 2016; Wang et al., 2018b; Wilhelm and Guizzetti, 2015) . However, glial activation following EtOH exposure may also have a neuroprotective role as activated glial cells can either produce antiinflammatory cytokines such as IL-10 and TGF-b or phagocytose apoptotic neurons in response to neuronal damage (Chastain and Sarkar, 2014; Saito et al., 2016) . In this study, the expression of microglia and astrocytes is increased by EtOH exposure and reduced by 4-PBA, a pattern similar to c-caspase-3 expression. However, it is difficult to distinguish whether glial activation is the result of secondary response to neuronal damage or a direct effect of EtOH exposure. Future experiments are necessary to address the role of glial activation in EtOH neurotoxicity.
4-PBA is a small fatty acid that has been approved by the Food and Drug Administration to treat urea cycle disorders (Lichter-Konecki et al., 2011) . Recent studies have significantly expanded the application of 4-PBA as a therapeutic molecule to a variety of diseases like cancer, cystic fibrosis, Alzheimer's disease, and Parkinson's disease (Camacho et al., 2007; Cuadrado-Tejedor et al., 2011; Zeitlin et al., 2002; Zhou et al., 2011) . The therapeutic effects of 4-PBA in these diseases are believed to involve 2 primary mechanisms: a chemical chaperone and histone deacetylase inhibitor (HDACi) (Basseri et al., 2009; Miller et al., 2011; Xiao et al., 2011; Yam et al., 2007) . In this study, 4-PBA alone did not exhibit toxic effects on developing brains, but reduced EtOH-induced expression of ER stress markers. This may result from the HDAC inhibitory property of 4-PBA as it has been shown that deacetylation can regulate the stability and transcriptional activity of XBP1s and other UPR proteins (Bobrovnikova-Marjon et al., 2008; Karanam et al., 2007; Lassot et al., 2005; Wang et al., 2011) . 4-PBA inhibition of EtOH-induced ER stress in the developing brain may also result from its property as a chemical chaperone that facilitates protein folding and reduces ER stress (Cortez and Sim, 2014; Kolb et al., 2015) . More importantly, 4-PBA significantly reduced the EtOH-induced cell death, implying a potential therapeutic value of 4-PBA in treating FASD.
Taken together, this is the first study to show that 4-PBA offers protection against EtOH neurotoxicity in the developing brain. Although the mechanisms underlying the therapeutic effects of 4-PBA require further investigation, our study suggests that targeting ER stress may provide an effective therapeutic approach for FASD.
